Keynote: Having our cake and eating it too: Precise and efficient radiation therapy - Ballroom 4
June 5, 2025 from 9:00am EDT to 9:45am EDT
Speakers / Panelists
-
Keynote: Having our cake and eating it too: Precise and efficient radiation therapy - Ballroom 4
June 5, 2025 from 9:00am EDT to 9:45am EDT
Karl Otto
Chief Science Officer
Karl Otto
Karl Otto
Chief Science Officer
Dr. Karl Otto has explored several pathways in his career as a medical physicist, including clinical practice, academic research and industry. Karl is currently the Chief Science Officer at Radformation, a company that develops and deploys radiation therapy software. Prior to its acquisition by Radformation in 2024, Karl was co-founder and CEO of Limbus AI. Limbus’ focus was AI for radiation therapy, particularly for automatic segmentation of medical images. Prior to Limbus, Karl spent 2 years educating himself about AI, which he has been passionate about since attending his first AI conference in 2006. Over his career Karl developed and licensed several technologies to radiation therapy companies. Karl is also an adjunct professor at UBC and has roughly ten years of clinical experience. Karl’s career focus has been on developing radiation therapy technology that has a high clinical impact. He’s sometimes referred to as “Mister VMAT” due to his development of Volumetric Modulated Arc Therapy, which was the basis for Varian’s RapidArc treatment planning and delivery system. VMAT is now the most common form of radiation treatment globally.